View:
48/F Bank
of China Tower
1 Garden
Road, Hong Kong
November
16, 2009
|
Assistant
Director
United
States Securities and Exchange Commission
100
F. Street, N.E.
Washington,
D.C. 20549
|
|
Re:
|
China
Cord Blood Corporation (the “Company”)
Registration
Statement on Form F-1 (Registration No. 333-161602) (the “Registration
Statement”)
|
In
accordance with Rule 461 and Rule 430A under the Securities Act of 1933, as
amended, the Company has respectfully requested that the effective date and time
of the above referenced Registration Statement and the Company’s Registration
Statement on Form 8-A filed under the Securities Exchange Act of 1934, as
amended, be accelerated to 5:30 p.m. on November 18, 2009 or as soon thereafter
as practicable.
In
connection with this request, the Company hereby acknowledges that:
|
·
|
should
the Securities Exchange Commission (the “Commission”) or the Commission’s
staff (the “Staff”), acting pursuant to delegated authority, declare the
filing effective, it does not foreclose the Commission from taking any
action with respect to the filing;
|
|
·
|
the
action of the Commission or the Staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve the Company
from its full responsibility for the adequacy and accuracy of the
disclosure in the filing; and
|
|
·
|
the
Company may not assert Staff comments and the declaration of effectiveness
as a defense in any proceeding initiated by the Commission or any person
under the federal securities laws of the United
States.
|
The
Company hereby acknowledges that it is aware of its responsibilities under the
Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as
amended.
Very
truly yours,
CHINA CORD BLOOD
CORPORATION
By: /s/ Albert
Chen
Name: Albert
Chen
Title: Chief Financial
Officer